Vistin Pharma ASA: Invitation to Q2 2025 conference call
Vistin Pharma ASA: Invitation to Q2 2025 conference call
Oslo, Norway, 08 August 2025
Vistin Pharma ASA will release its second quarter and YTD 2025 results on Friday
15th of August 2025. Vistin Pharma will host a conference call for all
shareholders and interested parties at the same day at 08:30 CET. There will be
a Q&A session following the management discussion.
The conference call will be held in English.
The second quarter conference call will be available via web and audio through
the following access points:
Webcast:
https://edge.media-server.com/mmc/p/vvot47w4
Telephone conference (online registration):
https://register-conf.media-
server.com/register/BI65266ce5abba480f9cda4180274c996b
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
[email protected]
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.